{"name": "ProtAb",
 "permalink": "protab",
 "crunchbase_url": "http://www.crunchbase.com/company/protab",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "972 2 677 8175",
 "description": "Cytokine Regulation BioPharma Company",
 "created_at": "Sat Apr 24 03:40:19 UTC 2010",
 "updated_at": "Wed Jul 07 04:26:14 UTC 2010",
 "overview": "\u003Cp\u003EProtAb Ltd. develops treatments for autoimmune diseases. The company\u00e2\u20ac\u2122s main product is Proximab which is a monoclonal antibody for the treatment of rheumatoid arthritis and other autoimmune diseases such as diabetes. The company was founded in 2005 and is based in Jerusalem, Israel. ProtAb Ltd. operates as a subsidiary of HBL Hadasit Bio Holdings Ltd.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[142,
       56],
      "assets/images/resized/0008/4788/84788v1-max-150x150.png"],
     [[142,
       56],
      "assets/images/resized/0008/4788/84788v1-max-250x250.png"],
     [[142,
       56],
      "assets/images/resized/0008/4788/84788v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$4M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.hbl.co.il/portfolio_company.asp?ID=5",
    "source_description": "ProtAb has recently raised $4M from HBL and two of the largest life science venture capital firms in Israel,",
    "raised_amount": 4000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Pontifax",
         "permalink": "pontifax",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Clal Biotechnology",
         "permalink": "clal-biotechnology",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0005/0268/50268v2-max-150x150.png"],
             [[250,
               60],
              "assets/images/resized/0005/0268/50268v2-max-250x250.png"],
             [[305,
               74],
              "assets/images/resized/0005/0268/50268v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBL Hadasit Bio Holdings",
         "permalink": "hbl-hadasit-bio-holdings",
         "image":
          {"available_sizes":
            [[[150,
               62],
              "assets/images/resized/0010/2214/102214v1-max-150x150.png"],
             [[185,
               77],
              "assets/images/resized/0010/2214/102214v1-max-250x250.png"],
             [[185,
               77],
              "assets/images/resized/0010/2214/102214v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Kiryat Hadassah",
    "address2": "",
    "zip_code": "91120",
    "city": "Jerusalem",
    "state_code": null,
    "country_code": "ISR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}